ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Blockage of FOXP3 transcription factor dimerization and FOXP3/AML1 interaction inhibits T regulatory cell activity: sequence optimization of a peptide inhibitor

Lozano, Teresa; Gorraiz, Marta; Lasarte-Cia, Aritz; Ruiz, Marta; Rabal, Obdulia; Oyarzabal, Julen; Hervas-Stubbs, Sandra; Llopiz, Diana; Sarobe, Pablo; Prieto, Jesus; Casares, Noelia*; Lasarte, Juan Jose*
Oncotarget2017-9-22DOI: 10.18632/oncotarget.17845
27被引12阅读
引用收藏
分享

摘要

Although T regulatory cells (Treg) are essential for the prevention of autoimmune diseases, their immunoregulatory function restrains the induction of immune responses against cancer. Thus, development of inhibitors of FOXP3, a key transcription factor for the immunosuppressive activity of Treg, might give new therapeutic opportunities. In a previous work we identified a peptide (named P60) able to enter into the cells, bind to FOXP3, and impair Treg activity in vitro and in vivo. Here we show that P60 binds to the intermediate region of FOXP3 and inhibits its homodimerization as well as its interaction with the transcription factor AML1. Alanine-scanning of P60 revealed the relevance of each position on FOXP3 binding, homodimerization, association with AML1 and inhibition of Treg activity. Introduction of alanine at positions 2, 5 and 11 improved the activity of the original P60, whereas alanine mutations at positions 1, 7, 8, 9, 10 and 12 were detrimental. Multiple mutation experiments allowed us to identify peptides with higher FOXP3 binding affinity and stronger biological activity than the original P60. Head to tail macrocyclization of peptide P60-D2A-S5A improved Treg inhibition and enhanced anti-tumor activity of anti-PD1 antibodies in a model of hepatocellular carcinoma. Introduction of a D-aminoacid at position 2 augmented significantly microsomal stability while maintained FOXP3 binding capacity and Treg inhibition in vitro. In vivo, when combined with the cytotoxic T-cell epitope AH1, it induced protection against CT26 tumor implantation. This study provides important structure-function relationships essential for further drug design to inhibit Treg cells in cancer.

学科与关键词

关键词
Foxp3Tregpeptide inhibitorcancerimmunomodulation
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Oncotarget
发表日期
2017-09-22
卷期
第 8 卷, 第 42 期
页码
71709-71724
DOI
10.18632/oncotarget.17845
语言
ENGLISH
成果收录
SCIE
资助标注
Ministerio de Educacion y Ciencia [SAF2013-42772-R, SAF2016-78568-R]; Fundacion Ramon Areces; FPU grant (Ministerio de Educacion, Cultura y Deporte, Spain)

作者

  • L

    Lozano, Teresa (第一作者)

  • G

    Gorraiz, Marta

查看全部 12 位作者收起作者
  • L

    Lasarte-Cia, Aritz

  • R

    Ruiz, Marta

  • R

    Rabal, Obdulia

  • O

    Oyarzabal, Julen

  • H

    Hervas-Stubbs, Sandra

  • L

    Llopiz, Diana

  • S

    Sarobe, Pablo

  • P

    Prieto, Jesus

  • C

    Casares, Noelia (通讯)

  • L

    Lasarte, Juan Jose (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417